Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

156 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003.
Fluit AC, Florijn A, Verhoef J, Milatovic D. Fluit AC, et al. J Antimicrob Chemother. 2005 Jul;56(1):133-8. doi: 10.1093/jac/dki167. Epub 2005 May 25. J Antimicrob Chemother. 2005. PMID: 15917287
Daptomycin in vitro susceptibility in European Gram-positive clinical isolates.
Fluit AC, Schmitz FJ, Verhoef J, Milatovic D. Fluit AC, et al. Int J Antimicrob Agents. 2004 Jul;24(1):59-66. doi: 10.1016/j.ijantimicag.2003.12.014. Int J Antimicrob Agents. 2004. PMID: 15225863
In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants.
Fluit AC, Schmitz FJ, Verhoef J, Milatovic D. Fluit AC, et al. Antimicrob Agents Chemother. 2004 Mar;48(3):1007-11. doi: 10.1128/aac.48.3.1007-1011.2004. Antimicrob Agents Chemother. 2004. PMID: 14982796 Free PMC article.
Antimicrobial susceptibility and serotypes of nasopharyngeal Streptococcus pneumoniae in children with pneumonia and in children attending day-care centres in Fortaleza, Brazil.
Rey LC, Wolf B, Moreira JL, Milatovic D, Verhoef J, Farhat CK. Rey LC, et al. Int J Antimicrob Agents. 2002 Aug;20(2):86-92. doi: 10.1016/s0924-8579(02)00128-0. Int J Antimicrob Agents. 2002. PMID: 12297356
In vitro activity of new ketolides against macrolide-susceptible and -resistant Staphylococcus aureus isolates with defined resistance gene status.
Schmitz FJ, Petridou J, Milatovic D, Verhoef J, Fluit AC, Schwarz S. Schmitz FJ, et al. J Antimicrob Chemother. 2002 Mar;49(3):580-2. doi: 10.1093/jac/49.3.580. J Antimicrob Chemother. 2002. PMID: 11864966 No abstract available.
In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe.
Milatovic D, Schmitz FJ, Verhoef J, Fluit AC. Milatovic D, et al. J Antimicrob Chemother. 2002 Aug;50(2):293-9. doi: 10.1093/jac/dkf098. J Antimicrob Chemother. 2002. PMID: 12161416 No abstract available.
In vitro activity of AR-709 against Streptococcus pneumoniae.
Jansen WT, Verel A, Verhoef J, Milatovic D. Jansen WT, et al. Antimicrob Agents Chemother. 2008 Mar;52(3):1182-3. doi: 10.1128/AAC.01332-07. Epub 2008 Jan 7. Antimicrob Agents Chemother. 2008. PMID: 18180358 Free PMC article.
In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus.
Schmitz FJ, Fluit AC, Milatovic D, Verhoef J, Heinz HP, Brisse S. Schmitz FJ, et al. J Antimicrob Chemother. 2000 Jul;46(1):109-13. doi: 10.1093/jac/46.1.109. J Antimicrob Chemother. 2000. PMID: 10882698
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Jansen WT, Verel A, Verhoef J, Milatovic D. Jansen WT, et al. Antimicrob Agents Chemother. 2007 Sep;51(9):3420-4. doi: 10.1128/AAC.00100-07. Epub 2007 Jul 2. Antimicrob Agents Chemother. 2007. PMID: 17606689 Free PMC article.
156 results
Jump to page
Feedback